Navigation Links
Life-saving epinephrine under utilized by paramedics

Epinephrine is the first line of treatment for patients suffering from anaphylaxis, a life-threatening allergic reaction. A delay in using epinephrine is common in severe food allergic reaction deaths. Yet according to a new study presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Anaheim, Calif. Nov. 8-13, only 15 percent of those experiencing anaphylaxis receive epinephrine from paramedics. Authors conclude that "paramedic education on the indications and use of epinephrine for allergic reactions and anaphylaxis needs to be implemented."

Title: Paramedic Assessment and Treatment of Patients with Allergic Reactions and Anaphylaxis in a Large Urban Pre-Hospital System

Lead Author: Nabil El Sanadi, M.D., chief medical officer of emergency medicine at Broward Health

By the Numbers: A total of 92 paramedic run sheets were reviewed 40 were allergic reactions and 52 were anaphylaxis. Only 15 percent of patients with anaphylaxis and nearly 9 percent with an allergic reaction were treated with epinephrine.


Contact: Christine Westendorf
American College of Allergy, Asthma, and Immunology

Page: 1

Related medicine news :

1. Life-saving primary PCI rising in Stent for Life countries
2. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
3. 2 NIH studies show power of epidemiology research; Underscore need to address health disparities
4. Researchers discover how underground rodent wards off cancer
5. Advancing understanding of treatment through clinical trials
6. Automated calls help patients in under-developed countries manage blood pressure, U-M study finds
7. Higher risk of maternal complications/preterm deliveries for women undergoing multiple cesareans
8. Higher risk of maternal complications/preterm deliveries for women undergoing multiple caesareans
9. Sudden cardiac death in Ontario under age 40 - is exercise dangerous?
10. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
11. Theory: Music underlies language acquisition
Post Your Comments:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: